InvestorsHub Logo
Followers 3
Posts 1287
Boards Moderated 0
Alias Born 06/06/2017

Re: Abundance88 post# 34198

Thursday, 10/19/2023 5:35:56 PM

Thursday, October 19, 2023 5:35:56 PM

Post# of 34627
I think it's very bullish that Juvenescence prefers to develop a Sulforathane product with LEXX and canceled an existing deal with Evgen, which cost them some money. They must have tried their Sulforathane product with DehydraTECH and saw much better bioavailability, which would be a great endorsement of the technology.
Thanks again to pieinthesky for leading us down this trail!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News